The European Partnership for Personalised Medicine (EP PerMed) has launched the Fast-Track 2026 Programme to accelerate the validation and adoption of innovative personalised medicine solutions. This program supports start-ups, early-stage ventures, and small research teams in conducting validation studies at specialized European centers, helping them advance their innovations by at least one Technology Readiness Level (TRL) and prepare for market entry.

📅 Call Timeline

• Call Opening: 2 December 2025
• Stage 1 Submission Deadline: 10 March 2026 (18.00)
• Stage 1 Outcome Notification: 17 April 2026
• Stage 2 (Work Plan) Submission Deadline: 20 May 2026
• Final Outcome Notification: 9 June 2026
• Project Implementation: 30 June 2026 – 31 March 2027

✅ Eligibility

• Incorporated start-ups or teams/researchers affiliated with academic or healthcare research organizations registered in an EU Member State or Horizon Europe Associated Country are eligible.
• Private individuals are not eligible.
• The proposed solution must be at least at TRL 3.

📂 Support Scope and Duration

• Validation projects must be no longer than 6 months.

Scope:

• The program uses lump sum funding.
• At least 70% of the allocated budget must be dedicated to validation services.
• The funding covers validation services and other eligible costs.

💶 Funding Opportunities

• Maximum Funding per Project: €80,000.
• Up to 5 projects will be funded.

📌 Useful Links

• Call Website
• Call Text Document
• Application Platform Guidance Document
• FAQ Document